Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

DEXTROMETHORPHAN  IMPURITY A CRS (10 MG)

DEXTROMETHORPHAN IMPURITY A CRS (10 MG)

NA

DISCOVER
PREKALLIKREIN ACTIVATOR IN ALBUMIN BRP (200 MG)

PREKALLIKREIN ACTIVATOR IN ALBUMIN BRP (200 MG)

70024-90-7

DISCOVER
Diclazuril for veterinary use- reference spectrum, Qty : n/a

Diclazuril for veterinary use- reference spectrum, Qty : n/a

NA

DISCOVER
Flunarizine dihydrochloride -reference spectrum, Qty : n/a

Flunarizine dihydrochloride -reference spectrum, Qty : n/a

NA

DISCOVER
Flunarizine dihydrochloride for system suitability CRS, 20mg

Flunarizine dihydrochloride for system suitability CRS, 20mg

30484-77-6

DISCOVER
SODIUM PROPIONATE - REFERENCESPECTRUM (N/A)

SODIUM PROPIONATE - REFERENCESPECTRUM (N/A)

NA

DISCOVER
CLAZURIL FOR SYSTEM SUITABILITY CRS (10 MG)

CLAZURIL FOR SYSTEM SUITABILITY CRS (10 MG)

101831-36-1

DISCOVER
OXALIPLATIN CRS (250 MG)

OXALIPLATIN CRS (250 MG)

61825-94-3

DISCOVER
OXALIPLATIN IMPURITY B CRS (22 MG)

OXALIPLATIN IMPURITY B CRS (22 MG)

NA

DISCOVER
OXALIPLATIN IMPURITY C CRS (20 MG)

OXALIPLATIN IMPURITY C CRS (20 MG)

NA

DISCOVER
OXALIPLATIN IMPURITY D CRS (15 MG)

OXALIPLATIN IMPURITY D CRS (15 MG)

NA

DISCOVER
DICHLORODIAMINOCYCLOHEXAN EPLATINUM CRS (15 MG)

DICHLORODIAMINOCYCLOHEXAN EPLATINUM CRS (15 MG)

NA

DISCOVER